CN Patent

CN117858866A — 用于制备色胺衍生物的方法

Assigned to GH Research Ireland Ltd · Expires 2024-04-09 · 2y expired

What this patent protects

提供了一种用于制备5‑甲氧基‑N,N‑二甲基色胺(5‑MeO‑DMT)的方法，其从5‑甲氧基‑1H‑吲哚开始。可以经由形成5‑MeO‑DMT的盐诸如富马酸盐来纯化所获得的产物。

USPTO Abstract

提供了一种用于制备5‑甲氧基‑N,N‑二甲基色胺(5‑MeO‑DMT)的方法，其从5‑甲氧基‑1H‑吲哚开始。可以经由形成5‑MeO‑DMT的盐诸如富马酸盐来纯化所获得的产物。

Drugs covered by this patent

nirogacestat-hydrobromide (NIROGACESTAT HYDROBROMIDE)

Patent Metadata

Patent number: CN117858866A
Jurisdiction: CN
Classification: —
Expires: 2024-04-09
Drug substance claim: No
Drug product claim: No
Assignee: GH Research Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.